Relationship between ischemic heart disease and C-reactive protein.

Article Sidebar

Published: Aug 15, 2017
DOI: https://doi.org/10.26807/remcb.v36i1-2.259
Keywords:
ischemic heart disease, inflammation, interleukins, proteins of acute phase, C-reactive protein.

Main Article Content

Rosa Colina Cifuentes
Rommel Espinoza de los Monteros
James Franco
Bolívar Saenz
Luis Alejandro Cárdenas

Abstract

The cardiovascular diseases are associated with prolonged or persistent inflammatory processes causing the increased levels of C-reactive protein (CRP) as acute phase reactants. The objective of the study was to relate the Hscrp in patients with ischemic heart disease. We analysed a total of 91 people, 50 patients with inclusion criteria for the diagnosis of ischemic heart disease and 41 patients with no inclusión criteria, chosen in the area of outpatient and hospitalization of the services of Cardiology of the Hospital of specialties of the armed forces. N ° 1 - Quito and Carlos Andrade Marin Hospital (Hospital IESS - Quito).


Among the habits in the Group of cases prevailed 11 smoking (22 %) followed by alcoholism and smoking together 9 (18 %). 25 (50 %) of this group said have any habit.


Level of glycemic in fasting more than 100 mg/dl found Association of ischemic heart disease (OR = 4.13, 95 % CI: 1.54-11.0), (p = 0.03).


The immediate reading of the PCR-us had no significant difference, p = 0.20 CI 95 % between the two study groups, the reading of the PCR-us 30 minutes p = 0.21 CI of 95 %.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Colina Cifuentes R, de los Monteros RE, Franco J, Saenz B, Cárdenas LA. Relationship between ischemic heart disease and C-reactive protein. REMCB [Internet]. 2017Aug.15 [cited 2024Jul.3];36(1-2):9-15. Available from: https://remcb-puce.edu.ec/remcb/article/view/259
Issue
Vol. 36 No. 1-2: Noviembre 2015
Section
Artículos Científicos

References

Andrade E, Waras R, Couto F, Couto R. 2011. Triglycerides/HDL-C ratio and high sensible C-reactive protein to the evaluation of cardiovascular risk. Jornal Brasileiro de Patologia e Medicina Laboratorial, 47 (2): 113-118.

Arqué M. 2009. Obtención, procesado y almacenaje de muestras de plasma sanguíneo. Centro de investigación biomédica en red enfermedades respiratorias.

Assay Max human C reactive Protein ELISA Kit, ASSAYPRO, Catalog No. EC1001-1. 2014.

Barba JR. 2007. Síndrome coronario agudo. Revista Mexicana de Patología Clínica, 54 (3): 116-135.

Braunwald’s 2011. Heart Disease: A Textbook of Cardiovascular Medicine. Novena Edición. Philadelphia. Pa: Saunders Elsevie: 49 pp.

Danesh J, Collins R, Appleby P, Peto R. 1998. Association of fibrinogen, C-reactive protein, albumin, or leukocyte with coronary heart disease. The Journal of the American Medical Association, 279: 1477-1482.

García J y Kaski JC. 1999. Cardiopatía Isquémica: marcadores de inflamación y riesgo cardiovascular. Revista Española de Cardiología, 52: 990-1003

Graciani A, Zuluaga M. 2008. Mortalidad cardiovascular atribuible a la presión arterial elevada en la población española de 50 años o más. Medicina Clínica, 131: 125-129

Jeremiah S, James D y Neaton. 2008. The Multiple Risk Factor Intervention Trial (MRFIT) Importance Then and Now. The Journal of the American Medical Association, 300(11):1343-1345.

Ridker PM, Cushman M, Stampfer MJ, Tracy RP, Hennekens CH. 1997. For systemic inflammation, in 543 apparently healthy men participating in the Physicians’ Health Study. The New England Journal of Medicine, 337(5):356.